Predictors of Relapse and Dropout During a 12-Week Relapse Prevention Program for Methamphetamine Users. J Psychoactive Drugs. 2015 Sep-Oct;47(4):317-24. Chen YC, Chen CK, Wang LJ.
Predictors of Relapse and Dropout During a 12-Week Relapse Prevention Program for Methamphetamine Users. Journal of Psychoactive Drugs, 47 (4), 317–324, 2015 Yi-Chih Chen, Chih-Ken Chen, Liang-Jen Wang.
Neurocognitive Profiles of Methamphetamine Users: Comparison of Those With or Without Concomitant Ketamine Use. Substance Use and Misuse. 2015;50:1778–1785.(SCI; IF=1.234; Psychiatry 103/140) Chen YC, Wang LJ, Lin SK, Chen CK*.
Predictors of Relapse and Dropout During a 12-week Relapse Prevention Program for Methamphetamine Users. Journal of Psychoactive Drugs. 2015; 47 (4), 317–324. (SCI; IF=1.308) Chen YC, Chen CK , Wang LJ*.
Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users. Drug Alcohol Depend. 2015 Mar 1;148:158-64. (SCI; IF=3.423; Psychiatry 41/140) Chen CK, Lin SK, Chen YC, Huang MC, Chen TT, Ree SC, Wang LJ*.
Trends in anxiolytic-hypnotic use and polypharmacy in Taiwan, 2002-2009: a nationwide, population-based survey. Psychiatr Serv. 2014 Feb 1;65(2):208-14. (SCI; IF=2.412; Psychiatry 64/140) Wang LJ*, Chen YC, Chen CK, Chou WJ, Chou MC.
Health care service utilization and associated factors among heroin users in northern Taiwan. Addictive Behaviors. 2013; 38(11):2635-2638. (SCI; IF=2.764; Substance Abuse 7/19) Chen YC, Chen CK , Lin SK, Chiang SC, Su LW, Wang LJ*.
Quetiapine Fumarate Augmentation for Patients with a Primary Anxiety Disorder or a Mood Disorder: a Pilot Study. BMC Psychiatry. 2012 Sep,12:162. (SCI; IF=2.552; Psychiatry 54/129) Chen YC, Chen CK*, Wang LJ.
Association of Salivary Dehydoepiandrosterone Levels and Symptoms in Patients with Attention Deficit Hyperactivity Disorder during Six Months of Treatment with Methylphenidate. Psychoneuroendocrinology 2011;36(8):1209-1216. (SCI; IF=5.809; Psychiatry 12/129) Wang LJ, Hsiao CC, Huang YS, Chiang YL, Ree SC, Chen YC, Wu YW, Wu CC, Shang ZY, Chen CK*.
Phospholipase A2 and Cyclooxygenase 2 Genes Influence the Risk of Interferon-α-induced Depresion by Regulating Polyunsaturated Fatty Acids Levels. Biol Psychiatry 2010;67:550-557. (SCI; IF=8.283; Psychiatry 5/129) Su KP, Huang SY, Peng CY, Lai HC, Huang CL, Chen YC, Aitchison KJ, Pariante CM*.
The Potential Risk Factors of Methadone Maintenance Therapy-A Mortality Case Report. Formosa Journal of Clinical Pharmacy. 2010;18(2):47-60. Lo CY, Lin YC, Chen YC, Chen YH*.
Clinical Effectiveness of Group Cognitive-behavioral Therapy for Primary and Secondary Insomnia. Taiwanese Journal of Psychiatry 2009;23:207-14. Chen YC, Huang YS, Chen CK*.
Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder; a 12-month follow-up. Psychiatry Clin Neurosci. 2009 Feb;63(1):17-22. (SCI; IF=2.133; Psychiatry 71/129) Chen CK, Chen YC, Huang YS*.